- Home
- / Hanmi Pharmaceutical
Hanmi Pharmaceutical
Revenue
₩1.2 T
FY, 2021
Market Capitalization
₩3.2 T
2023-01-27
Hanmi Pharmaceutical Summary
Company summary
- Overview
- Hanmi Pharmaceutical is a company focused on the development and commercialization of pharmaceutical products. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases.
- Type
- Public
- Status
- Active
- Founded
- 1973
- HQ
- Seoul, KR | view all locations
- Website
- http://www.hanmipharm.com/
- Cybersecurity rating
- ESG rating
LocationsView all
1 location detected
Seoul, Seoul HQ
Korea (Republic of)
14 Wiryeseong-daero, Songpa-gu
Hanmi Pharmaceutical Financials
Summary financials
- Revenue (Q2, 2022)
- ₩317.1B
- Gross profit (Q2, 2022)
- ₩168.9B
- Net income (Q2, 2022)
- ₩22.7B
- Cash (Q2, 2022)
- ₩154.1B
- EBIT (Q2, 2022)
- ₩28.4B
- Enterprise value
- $3.6T
News
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension